metricas
covid
Medicina Clínica (English Edition) Effectiveness of tixagevimab/cilgavimab in reducing SARS-CoV-2 infections, hospi...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Effectiveness of tixagevimab/cilgavimab in reducing SARS-CoV-2 infections, hospitalizations and mortality in inmunocompromised patients
Efectividad de tixagevimab/cilgavimab en la reducción de la infección, ingresos hospitalarios y mortalidad por SARS-CoV-2 en pacientes inmunodeprimidos
Marc Marti-Pastora,
Corresponding author
mmartip27@gmail.com

Corresponding author.
, Ricardo Bou-Monterdea, Lucia Ciancotti-Olivera, Marta Alcover-Ponsa, Aurora Amorós Canteroa, Raquel Sánchez-Lopezosab, Neus Montañana-Rosellb
a Servicio de Medicina Preventiva y Salud Pública, Hospital Univesitario de la Ribera, Alzira, Valencia. Spain
b Servicio de Medicina Interna, Hospital Univesitario de la Ribera, Alzira, Valencia. Spain
Read
136
Times
was read the article
0
Total PDF
136
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 10 6 0 6
2025 9 16 0 16
2025 8 18 0 18
2025 7 20 0 20
2025 6 7 0 7
2025 5 7 0 7
2025 4 11 0 11
2025 3 10 0 10
2025 2 4 0 4
2025 1 6 0 6
2024 12 6 0 6
2024 11 14 0 14
2024 10 8 0 8
2024 9 3 0 3
Show all

Follow this link to access the full text of the article